Tag: ISPOR

ISPOR ADDRESSES NEW CHALLENGES FOR IMPROVING EUROPEAN HEALTH CARE AT ANNUAL EUROPEAN CONGRESS

Princeton, NJ, USA, October 7, 2014 – The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) will hold its 17th Annual European Congress in Amsterdam from November 8-12, 2014. The theme of this year’s congress is: “New Challenges for Improving

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR Asia-Pacific Conference in Beijing, China to Focus on Health Care Reform, Big Data, and Patients in Asia

August 18, 2014 21:30 | Source: ISPOR Princeton, New Jersey, August 19, 2014 – The International Society for Pharmacoeconomics and Outcomes Research (ISPOR), in conjunction with the ISPOR Asia Consortium, and the China Pharmaceutical Association Pharmacoeconomics Society has organized the

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

Collaboration Between Regulators And HTA Organizations To Improve Health Care Decision Making

PRINCETON, NJ, June 25, 2014 (ISPOR) — As announced today by the European network for Health Technology Assessment (EUnetHTA) and European Medicines Agency (EMA), Value in Health, the official journal for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), was pleased to publish

Posted in ISPOR News & Press, Value in Health Tagged with: , , ,

The International Society For Pharmacoeconomics And Outcomes Research Examines The Role Of Big Data In Health Care Decision Making

Princeton, NJ, USA – Health care researchers, health technology assessors, manufacturers, governments, and patients will examine the role of “Big Data” in health care decision making at the ISPOR 19th Annual International Meeting. The meeting will take place May 31 – June

Posted in ISPOR News & Press Tagged with: , , , ,

What is the Role of ISPOR Regional Chapters in Health Technology Implementation?

Budapest, Hungary – Middle income countries often do not have a clear roadmap for the implementation of health technology assessment (HTA) in policy decisions. Since examples from high income countries may not be relevant, roadmaps for the implementation of HTA from

Posted in Value in Health Regional Issues Tagged with: , ,

Education Proves More Effective Than Reminders At Improving Hypertension Patient Medication Adherence

London, ON, Canada – Sub-optimal medication adherence with hypertension medication is associated with uncontrolled blood pressure and an increasing economic burden. Researchers, clinicians, and policy makers continue to explore new ways of promoting antihypertensive medication adherence, however, there is little consensus

Posted in Systematic Reviews, Value in Health Tagged with: , ,

Where Do We Need Best Practices In Development And Reimbursement Of Personalized Medicine?

Durham, NC, USA – Personalized medicine technologies are currently caught between high expectations of improving health outcomes and uncertainty about navigating the rapidly changing regulatory and reimbursement environment. This is because they do not fit neatly into the existing routes by

Posted in Policy Perspectives, Value in Health Tagged with: , , , ,